Mastercard Currently Down Seven Consecutive Days, on Pace for Longest Losing Streak Since September 2022 — Data Talk
Mastercard Incorporated Class A (MA) is currently at $443.71, down $1.37 or 0.31%
--Would be lowest close since May 3, 2024, when it closed at $443.58
--Currently down seven consecutive days; down 3.6% over this period
--Longest losing streak since Sept. 27, 2022, when it fell for nine straight trading days
--Worst seven day stretch since the seven days ending May 3, 2024, when it fell 4.09%
--Down 1.66% month-to-date
--Up 4.03% year-to-date
--Down 9.19% from its all-time closing high of $488.64 on March 21, 2024
--Up 21.56% from 52 weeks ago (May 31, 2023), when it closed at $365.02
--Down 9.19% from its 52-week closing high of $488.64 on March 21, 2024
--Up 21.87% from its 52-week closing low of $364.08 on Oct. 27, 2023
--Traded as low as $441.80; lowest intraday level since May 3, 2024, when it hit $436.90
--Down 0.74% at today's intraday low
All data as of 10:58:43 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 29, 2024 11:15 ET (15:15 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations